Skip to main content
. 2022 Apr 29;12:879423. doi: 10.3389/fcimb.2022.879423

Figure 10.

Figure 10

The regulations of the NF-κB and MAPK signaling pathways in hGECs by coaggregation between F. nucleatum subsp. polymorphum and S. gordonii by western blot. hGECs were pretreated with the TLR2/4 antagonist OxPAPC for 2 h (A) and 12 h (B), the NF-κB inhibitor BAY 11-7082 (B) for 2 h (C), the p38 MAPK inhibitor SB 239063 for 12 h (D) and the JNK MAPK inhibitor SP 600125 for 12 h (E).